Only two U.S. public companies, Johnson & Johnson and Microsoft, maintain the highest AAA credit rating, surpassing even the U.S. federal government's AA+ rating. This rating reflects their strong balance sheets, reliable cash flow, and ability to sustain dividends through economic downturns and interest rate shocks. Microsoft benefits from its recurring cloud revenue and a $627 billion contract backlog, despite heavy AI-related capital spending. Johnson & Johnson boasts 64 years of consecutive dividend increases and strong pharmaceutical and medical technology cash flows, despite ongoing litigation costs. For retirement investors, these AAA-rated stocks offer durable income and financial stability, though valuation discipline remains important.
Johnson & Johnson reported strong Q2 sales of $584 million for Spravato, a nasal spray for treatment-resistant depression, signaling robust market potential for psychedelic drugs. Jefferies highlights this growth supports the commercial viability of ...
Johnson & Johnson reported solid Q2 2026 results, achieving 6.6% annual revenue growth driven by strong Pharma and MedTech divisions. The company maintains a portfolio of over 15 blockbuster drugs and a promising pipeline, supporting its status as a ...
Johnson & Johnson reported better-than-expected Q2 2026 results with adjusted EPS of $2.90, surpassing estimates, and revenue of $25.31 billion, driven by strong pharmaceutical sales. Key growth came from the Innovative Medicine segment, with notable...
The FTSE 100 dropped 23 points to 10,506, pressured by mining stocks reacting to China's slower-than-expected 4.3% GDP growth in Q2, its weakest in three years. European markets also declined, while US futures rose, led by tech. PayPal shares surged ...
US stock futures rose after a softer-than-expected Consumer Price Index (CPI) report reduced the chances of a Federal Reserve rate hike in July. The market now awaits today's Producer Price Index (PPI) data, which could either confirm easing inflatio...
